# Raybow (Suzhou) Pharmaceutical Co., Ltd. – FDA Inspection, Sep 19, 2014

Source: https://www.keypedia.com/records/fda_inspections/raybow-suzhou-pharmaceutical-co-ltd/54ea1ec1-bcb1-4e23-a9f5-c6ba7be77b0e
Source feed: FDA_Inspections

> FDA inspection 910769 of Raybow (Suzhou) Pharmaceutical Co., Ltd., September 19, 2014. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 910769
- Company Name: Raybow (Suzhou) Pharmaceutical Co., Ltd.
- Inspection Date: 2014-09-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1273595 - 2025-05-22](https://www.keypedia.com/records/fda_inspections/raybow-suzhou-pharmaceutical-co-ltd/b5c82a64-8301-4677-9693-560497a8fa17)
- FDA Inspection 1071681 - 2018-10-18
- FDA Inspection 671664 - 2010-05-25

Company: https://www.keypedia.com/companies/raybow-suzhou-pharmaceutical-co-ltd/2e5c052c-d886-4fd4-8edc-0d28ff241ad3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c